Completed OBSERVATIONAL NCT02145533

Matrix Metalloproteinases (MMPs),Neutrophil Gelatinase-associated Lipocalin (NGAL) Tissue and Plasma Levels and Aneurysms

Evaluation of Plasma and Tissue Levels of Metalloproteinases and Neutrophil Gelatinase-associated Lipocalin in Arterial Aneurysms.

Sponsor: University of Catanzaro

Conditions MMPs and NGAL in Ruptured and Non-ruptured Aneurysms

Updated 7 times since 2017 Last updated: May 22, 2014 Started: Jan 31, 2010 Primary completion: Dec 31, 2013 Completion: Mar 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02145533, this observational or N/A phase trial focuses on MMPs and NGAL in Ruptured and Non-ruptured Aneurysms and remains completed. Sponsored by University of Catanzaro, it has been updated 7 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Dec 2019 — Jan 2021 [monthly]

Completed
Jun 2018 — Dec 2019 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Catanzaro

Data source: University of Catanzaro

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Catanzaro, Italy